Related Experiment Video

Updated: Jan 10, 2026

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
10:26

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

Published on: June 15, 2020

11.6K

An antimicrobial peptide as a potential therapy for bacterial pneumonia that alleviates antimicrobial resistance

Chao Zhong1, Yongtao He1, Jing Zou1

  • 1Institute of Pharmaceutics, School of Pharmacy, Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences, and Research Unit of Peptide Science, Chinese Academy of Medical Sciences, 2019RU066, Lanzhou University, Lanzhou, PR China.

Nature Communications
|November 25, 2025
PubMed

Insights

A novel antimicrobial peptide (AMP) shows potent activity against drug-resistant bacteria, including MRSA and K. pneumoniae. This peptide also restores antibiotic sensitivity and demonstrates therapeutic efficacy in pneumonia models.

Area of Science:

  • Microbiology
  • Biochemistry
  • Pharmacology

Background:

  • Bacterial pneumonia poses a significant global health challenge, exacerbated by rising antimicrobial resistance.
  • The emergence of multidrug-resistant bacteria necessitates the development of novel antimicrobial agents.
  • Antimicrobial peptides (AMPs) are a promising class of therapeutics due to their broad-spectrum activity and low resistance potential.

Purpose of the Study:

  • To report a novel linear antimicrobial peptide (AMP) with potential against multidrug-resistant bacteria.
  • To evaluate the stability, antimicrobial activity, and biocompatibility of the designed AMP.
  • To investigate the mechanisms of action and in vivo therapeutic efficacy of the AMP.

Main Methods:

  • Synthesis and characterization of a linear AMP composed of repeating (D-tryptophan)-(D-arginine)-(D-lysine) units.
  • In vitro assessment of antimicrobial activity against multidrug-resistant strains (e.g., MRSA, K. pneumoniae).
  • Evaluation of resistance development potential, mechanisms of action (membrane targeting, DNA binding, ROS, ATP depletion, metabolic interference), and biocompatibility.
  • In vivo efficacy testing in murine models of K. pneumoniae and MRSA pneumonia and lipopolysaccharide-induced lung injury.

Main Results:

  • The synthesized AMP demonstrated high stability and potent antimicrobial activity against key multidrug-resistant pathogens.
  • The peptide exhibited improved biocompatibility compared to conventional antibiotics.
  • Multiple mechanisms of action were identified, including membrane disruption and intracellular targets, suggesting low resistance development potential.
  • The AMP effectively alleviated bacterial burden in pneumonia models and reduced lung injury in vivo.

Conclusions:

  • This novel linear AMP represents a promising candidate for combating drug-resistant bacterial infections, including pneumonia.
  • The peptide's multifaceted mechanisms of action and in vivo efficacy highlight its therapeutic potential.
  • Further research into this AMP could lead to new strategies to overcome antimicrobial resistance.

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.1K
Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

13.0K

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
12.9K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
735
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.4K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
479
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.1K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
765